Cited by 303Antifungal resistance and susceptibilityImmunodeficiency and Autoimmune DisordersNeutropenia and Cancer Infections

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

Open access

Baddley, John W., Andes, David R., Marr, Kieren A., Kontoyiannis, Dimitrios P., Alexander, Barbara D., Kauffman, Carol A., Oster, Robert A., Anaissie, Elias J., Walsh, Thomas J., Schuster, Mindy G., Wingard, John R., Patterson, Thomas F., Ito, James I., Williams, O. Dale, Chiller, Tom, Pappas, Peter G.·2010·Clinical Infectious Diseases

DOI 10.1086/652768PMC PMC2874071

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Invasive aspergillosis (IA) is an important cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) recipients. The purpose of this study was to evaluate factors associated with mortality in transplant patients with IA. METHODS: Transplant patients from 23 US centers were enrolled from March 2001 to October 2005 as part of the Transplant Associated Infection Surveillance Network. IA cases were identified prospectively in this cohort through March 2006, and data were collected. Factors associated with 12-week all-cause mortality were determined by logistic regression analysis and Cox proportional hazards regression. RESULTS: Six-hundred forty-two cases of proven or probable IA were evaluated, of which 317 (49.4%) died by the study endpoint. All-cause mortality was greater in HSCT patients (239 [57.5%] of 415) than in SOT patients (78 [34.4%] of 227; P<.001). Independent poor prognostic factors in HSCT patients were neutropenia, renal insufficiency, hepatic insufficiency, early-onset IA, proven IA, and methylprednisolone use. In contrast, white race was associated with decreased risk of death. Among SOT patients, hepatic insufficiency, malnutrition, and central nervous system disease were poor prognostic indicators, whereas prednisone use was associated with decreased risk of death. Among HSCT or SOT patients who received antifungal therapy, use of an amphotericin B preparation as part of initial therapy was associated with increased risk of death. CONCLUSIONS: There are multiple variables associated with survival in transplant patients with IA. Understanding these prognostic factors may assist in the development of treatment algorithms and clinical trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1086/652768

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citation
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Self-citation
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Aşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315
Self-citation
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,446
Self-citation
Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 964
Untitled work
(2006) · PubMed · Cited by 906
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
Walsh, T. J., RAAD, I. I., Patterson, T. F., Chandrasekar, P. H., Donowitz, G. R., Graybill, R. J., Greene, R. E., Hachem, R. Y., Hadley, S., Herbrecht, R., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 749
Self-citation
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Cornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744
Epidemiology of Aspergillus Infections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation
Wald, A., Leisenring, W., van Burik, J., & Bowden, R. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/516480 · Cited by 742
Combination Antifungal Therapy for Invasive Aspergillosis
Marr, K. A., Boeckh, M., Carter, R. A., Kim, H. W., & Corey, L. (2004) · Clinical Infectious Diseases · doi:10.1086/423380 · Cited by 607
Self-citation

Flagged first, then by citations

Show all 32 references

Sorted by citations

Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“The global incidence of invasive aspergillosis was previously reported to be 200,000 cases with an associated mortality ranging from 30–80% [108], recently updated to >300,000 cases [20].”
Background
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
Taccone, F. S., den Abeele, A. V., Bulpa, P., Misset, B., Meersseman, W., Cardoso, T., Paiva, J.-A., Blasco-Navalpotro, M. Á., Laere, E. D., Dimοpoulos, G., et al. (2015) · Critical Care · doi:10.1186/s13054-014-0722-7 · Cited by 409
Molecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Arvanitis, M., Anagnostou, T., Fuchs, B. B., Caliendo, A. M., & Mylonakis, E. E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-13 · Cited by 367
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
Steinbach, W. J., Marr, K. A., Anaissie, E. J., Azie, N. E., Quan, S.-P., Meier‐Kriesche, H., Apewokin, S. K., & Horn, D. L. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.08.003 · Cited by 347
Self-citation
Diagnosis of severe respiratory infections in immunocompromised patients
Azoulay, É., Russell, L., de Louw, A. V., Metaxa, V., Bauer, P. R., Póvoa, P. M. S. R., Garnacho‐Montero, J., Martín‐Loeches, I., Mehta, S., Puxty, K. A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05906-5 · Cited by 365
ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12041 · Cited by 334
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03548.x · Cited by 331
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
Verweij, P. E., Ananda-Rajah, M. R., Andes, D. R., Arendrup, M. C., Brüggemann, R. J. M., Chowdhary, A., Cornely, O. A., Denning, D. W., Groll, A. H., Izumikawa, K., et al. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.001 · Cited by 328
Self-citation
Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Husain, S., & Camargo, J. F. (2019) · Clinical Transplantation · doi:10.1111/ctr.13544 · Cited by 313
Aspergillus fumigatus and Related SpeciesPreprint
Sugui, J. A., Kwon-Chung, K. J., Juvvadi, P. R., Latgé, J., & Steinbach, W. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019786 · Cited by 286
Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Mousset, S., Buchheidt, D., Heinz, W., Ruhnke, M., Cornely, O. A., Egerer, G., Krüger, W., Link, H., Neumann, S., Ostermann, H., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1867-1 · Cited by 254
Aspergillosis
Cadena, J., Thompson, G. R., & Patterson, T. F. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.008 · Cited by 256
Self-citation
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
Pagano, L., Akova, M., Dimopoulos, G., Herbrecht, R., Drgoňa, Ľ., & Blijlevens, N. M. A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq437 · Cited by 220
In vivo Hypoxia and a Fungal Alcohol Dehydrogenase Influence the Pathogenesis of Invasive Pulmonary Aspergillosis
Grahl, N., Puttikamonkul, S., Macdonald, J. M., Gamcsik, M. P., Ngo, L. Y., Hohl, T. M., & Cramer, R. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002145 · Cited by 217
Donor-Derived Fungal Infections in Organ Transplant Recipients: Guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice
Singh, N., Huprikar, S. S., Burdette, S. D., Morris, M. I., Blair, J. E., & Wheat, L. J. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04100.x · Cited by 190
Infections in liver transplant recipients
Romero, F. A. R. (2011) · World Journal of Hepatology · doi:10.4254/wjh.v3.i4.83 · Cited by 187
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021
Douglas, A. P., Smibert, O. C., Bajel, A. R., Halliday, C. L., Lavee, O., McMullan, B. J., Yong, M. K., van Hal, S. J., & Chen, S. C. ‐. (2021) · Internal Medicine Journal · doi:10.1111/imj.15591 · Cited by 188
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Girmenia, C., Raiola, A. M., Piciocchi, A., Algarotti, A., Stanzani, M., Cudillo, L., Pecoraro, C., Guidi, S., Iori, A. P., Montante, B., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.03.004 · Cited by 182
Invasive Fungal Infections in Solid Organ Transplant Recipients
Shoham, S., & Marr, K. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.28 · Cited by 176
Self-citation
Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus
Herbst, S., Shah, A., Mazón, M. J., Marzola, V., Jensen, B., Reed, A. K., Birrell, M. A., Saijo, S., Mostowy, S., Shaunak, S., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404556 · Cited by 178
Epidemiology and treatment approaches in management of invasive fungal infections
Ito, J. I., Kriengkauykiat, Dadwal, S., & Kriengkauykiat (2011) · Clinical Epidemiology · doi:10.2147/clep.s12502 · Cited by 185
Self-citation
Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies
Seo, S., Renaud, C., Kuypers, J. M., Chiu, C. Y., Huang, M.-L. W., Samayoa, E., Xie, H., Yu, G., Fisher, C. E., Gooley, T. A., et al. (2015) · Blood · doi:10.1182/blood-2014-12-617035 · Cited by 172
First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States
Wiederhold, N. P., Gil, V. G., Gutierrez, F., Lindner, J. R., Bataineh, M. T. A., McCarthy, D. I., Sanders, C. J., Fan, H., Fothergill, A. W., & Sutton, D. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02478-15 · Cited by 168
The pH-Responsive PacC Transcription Factor of Aspergillus fumigatus Governs Epithelial Entry and Tissue Invasion during Pulmonary Aspergillosis
Bertuzzi, M., Schrettl, M., Alcazar-Fuoli, L., Cairns, T. C., Muñoz, A., Walker, L. A., Herbst, S., Safari, M., Cheverton, A. M., Chen, D., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004413 · Cited by 158
Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis
Hata, K., Horii, T., Miyazaki, M., Watanabe, N.-A., Okubo, M., Sonoda, J., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-11 · Cited by 149
Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience
Neofytos, D., Treadway, S., Ostrander, D. B., Alonso, C. D., Dierberg, K. L., Nussenblatt, V. R., Durand, C. M., Thompson, C. B., & Marr, K. A. (2013) · Transplant Infectious Disease · doi:10.1111/tid.12060 · Cited by 134
Self-citation
Invasive Aspergillosis
Cadena, J., Thompson, G. R., & Patterson, T. F. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.015 · Cited by 146
Self-citation
Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
Petřík, M., Franssen, G. M., Haas, H., Laverman, P., Hörtnagl, C., Schrettl, M., Helbok, A., Lass‐Flörl, C., & Decristoforo, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2110-3 · Cited by 123
Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single‐centre study with focus on emerging pathogens
Corzo-León, D., Satlin, M. J., Soave, R., Shore, T. B., Schuetz, A. N., Jacobs, S. E., & Walsh, T. J. (2015) · Mycoses · doi:10.1111/myc.12318 · Cited by 111
Self-citation
Pathogenicity and virulence of Aspergillus fumigatus
Earle, K., Valero, C., Conn, D. P., Vere, G., Cook, P. C., Bromley, M., Bowyer, P., & Gago, S. (2023) · Virulence · doi:10.1080/21505594.2023.2172264 · Cited by 121
Epidemiology of Invasive Mold Infections in Lung Transplant Recipients
Doligalski, C. T., Benedict, K., Cleveland, A. A., Park, B., Derado, G., Pappas, P. G., Baddley, J. W., Zaas, D., Harris, M., & Alexander, B. D. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12691 · Cited by 109
Self-citation
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study
Neofytos, D., Chatzis, O., Nasioudis, D., Boely Janke, E., Doco Lecompte, T., Garzoni, C., Berger, C., Cussini, A., Boggian, K., Khanna, N., et al. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12898 · Cited by 108
Regulation of Sulphur Assimilation Is Essential for Virulence and Affects Iron Homeostasis of the Human-Pathogenic Mould Aspergillus fumigatus
Amich, J., Schafferer, L., Haas, H., & Krappmann, S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003573 · Cited by 93
Nationwide Surveillance of Azole Resistance in Aspergillus Diseases
Vermeulen, E., Maertens, J. A., Bel, A. D., Nulens, E., Boelens, J., Surmont, I., Mertens, A., Boel, A., & Lagrou, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00233-15 · Cited by 95
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
Mortensen, K. L., Johansen, H. K., Fuursted, K., Knudsen, J. D., Gahrn-Hansen, B., Jensen, R. H., Howard, S. J., & Arendrup, M. C. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1229-7 · Cited by 92
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study
Koehler, P., Hamprecht, A., Bader, O., Bekeredjian-Ding, I., Buchheidt, D., Doelken, G., Elias, J., Haase, G., Hahn-Ast, C., Karthaus, M., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.10.019 · Cited by 91
Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus
Lepak, A. J., Marchillo, K., VanHecker, J., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01355-13 · Cited by 88
Self-citation
Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation
Fisher, C. E., Hohl, T. M., Fan, W., Storer, B. E., Levine, D., Zhao, L., Martin, P. J., Warren, E. H., Boeckh, M., & Hansen, J. A. (2017) · Blood · doi:10.1182/blood-2016-10-743294 · Cited by 90
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
Russo, A., Tiseo, G., Falcone, M., & Menichetti, F. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00315-4 · Cited by 93
Attributable Hospital Cost and Antifungal Treatment of Invasive Fungal Diseases in High-Risk Hematology Patients: an Economic Modeling Approach
Ananda-Rajah, M. R., Cheng, A., Morrissey, C. O., Spelman, T. D., Dooley, M. J., Neville, A. M., & Slavin, M. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01423-10 · Cited by 85
Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study
Even, C., Bastuji‐Garin, S., Hicheri, Y., Pautas, C., Botterel, F., Maury, S., Cabanne, L., Bretagne, S., & Cordonnier, C. (2010) · Haematologica · doi:10.3324/haematol.2010.030825 · Cited by 84
Cutaneous Invasive Aspergillosis
Bernardeschi, C., Foulet, F., Oro, S., Ortonne, N., Sitbon, K., Quereux, G., Lortholary, O., Chosidow, O., & Bretagne, S. (2015) · Medicine · doi:10.1097/md.0000000000001018 · Cited by 79
Lung Transplantation for Cystic Fibrosis: Results, Indications, Complications, and Controversies
Sayah, D. M., Belperio, J. A., Weigt, S. S., & Lynch, J. P. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1547347 · Cited by 79
Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis
Campoli, P., Abdallah, Q. A., Robitaille, R., Solis, N. V., Fielhaber, J. A., Kristof, A. S., Laverdière, M., Filler, S. G., & Sheppard, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00637-11 · Cited by 77
Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Ruhnke, M., Cornely, O. A., Schmidt‐Hieber, M., Alakel, N., Boell, B., Buchheidt, D., Christopeit, M., Hasenkamp, J., Heinz, W., Hentrich, M., et al. (2020) · Mycoses · doi:10.1111/myc.13082 · Cited by 76
Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study
López‐Medrano, F., Fernández‐Ruiz, M., Silva, J. T., Carver, P. L., van Delden, C., Merino, E., Pérez‐Sáez, M. J., Montero, M., Coussement, J., Mazzolin, M. D. A., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13837 · Cited by 76
Updates in Laboratory Diagnostics for Invasive Fungal Infections
Salcedo, D. A. T., & Powers‐Fletcher, M. V. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01487-19 · Cited by 94
Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
Lamoth, F., Lewis, R. E., Walsh, T. J., & Kontoyiannis, D. P. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab163 · Cited by 74
Self-citation
Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers
Chalmers, S. J., Khawaja, A. I., Wieruszewski, P. M., Gajic, O., & Odeyemi, Y. (2019) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v8.i5.74 · Cited by 74
The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis
Fisher, C. E., Stevens, A. M., Leisenring, W. M., Pergam, S. A., Boeckh, M., & Hohl, T. M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit393 · Cited by 72
Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value
Park, S. Y., Lim, C., Lee, S., Choi, S., Kim, Y. S., Woo, J. H., Song, J., Kim, M. Y., Chae, E. J., Do, K., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.08.007 · Cited by 71
Posaconazole Pharmacodynamic Target Determination against Wild-Type and Cyp51 Mutant Isolates of Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis
Lepak, A. J., Marchillo, K., VanHecker, J., & Andes, D. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01279-12 · Cited by 71
Self-citation
Invasive fungal infections in acute leukemia
Bhatt, V. R., Viola, G. M., & Ferrajoli, A. (2011) · Therapeutic Advances in Hematology · doi:10.1177/2040620711410098 · Cited by 71
The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus‐related lung disease
Kolwijck, E., & van de Veerdonk, F. L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344404 · Cited by 69
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review
Bassetti, M., Peghin, M., & Vena, A. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0183-9 · Cited by 67
Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis
Dufresne, S. F., Datta, K., Li, X., Dadachova, E., Staab, J. F., Patterson, T. F., Feldmesser, M., & Marr, K. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042736 · Cited by 66
Self-citation
Interleukin 1α Is Critical for Resistance against Highly Virulent Aspergillus fumigatus Isolates
Caffrey-Carr, A. K., Kowalski, C. H., Beattie, S. R., Blaseg, N. A., Upshaw, C. R., Thammahong, A., Lust, H. E., Tang, Y., Hohl, T. M., Cramer, R. A., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00661-17 · Cited by 62
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response
Neofytos, D., García‐Vidal, C., Lamoth, F., Lichtenstern, C., Perrella, A., & Vehreschild, J. J. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05958-3 · Cited by 65
Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus
Arendrup, M. C., Verweij, P. E., Mouton, J. W., Lagrou, K., & Meletiadis, J. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx319 · Cited by 61
Solid-state NMR molecular snapshots of Aspergillus fumigatus cell wall architecture during a conidial morphotype transition
Lamon, G., Lends, A., Valsecchi, I., Wong, S. S. W., Duprès, V., Lafont, F., Tolchard, J. L., Schmitt, C., Mallet, A., Grélard, A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212003120 · Cited by 61
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
Ráčil, Z., Winterová, J., Kouba, M., Žák, P., Malášková, L., Burešová, L., Tošková, M., Lengerová, M., Kocmanová, I., Weinbergerová, B., et al. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02186.x · Cited by 58
Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance®registry analysis
Husain, S., Silveira, F. P., Azie, N. E., Franks, B., & Horn, D. (2016) · Medical Mycology · doi:10.1093/mmy/myw086 · Cited by 55
Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases—the role of factors affecting assay performance
Ráčil, Z., Kocmanová, I., Tošková, M., Burešová, L., Weinbergerová, B., Lengerová, M., Rolencová, M., Winterová, J., Hrnčířová, K., Volfová, P., et al. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.09.011 · Cited by 54
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
Kontoyiannis, D. P., Selleslag, D., Mullane, K. M., Cornely, O. A., Hope, W. W., Lortholary, O., Croos‐Dabrera, R., Lademacher, C., Engelhardt, M. F., & Patterson, T. F. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx423 · Cited by 53
Self-citation
Successfully non-surgical management of flail chest as first manifestation of multiple myeloma: A case report
Muñoz-Bermúdez, R., Abella, E., Zuccarino, F., Masclans, J. R., & Nolla‐Salas, J. (2019) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v8.i5.59 · Cited by 54
CD4+T Cells Mediate the Protective Effect of the Recombinant Asp f3-Based Anti-Aspergillosis Vaccine
Díaz-Arévalo, D., Bagramyan, K. A., Hong, T., Ito, J. I., & Kalkum, M. (2011) · Infection and Immunity · doi:10.1128/iai.01311-10 · Cited by 53
Self-citation
Novel antifungal agents: a patent review (2013 - present)
Castelli, M. V., Derita, M., & López, S. N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1261113 · Cited by 53
Risk Factors, Clinical Characteristics, and Outcomes of Invasive Fungal Infections in Solid Organ Transplant Recipients
Bodro, M., Sabé, N., Grange, A. G., Ayats, J., Baliellas, C., Roca, J., Melilli, E., & Carratalà, J. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.09.059 · Cited by 52
Invasive Aspergillosis After Kidney Transplant: Case-Control Study
Heylen, L., Maertens, J. A., Naesens, M., Wijngaerden, E. V., Lagrou, K., Bammens, B., Claes, K. J., Evenepoel, P., Meijers, B. K. I., Kuypers, D. R. J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ103 · Cited by 51
Human MAIT cells are rapidly activated by Aspergillus spp. in an APC‐dependent manner
Jahreis, S., Böttcher, S., Hartung, S., Rachow, T., Rummler, S., Dietl, A., Haas, H., Walther, G., Hochhaus, A., & von Lilienfeld‐Toal, M. (2018) · European Journal of Immunology · doi:10.1002/eji.201747312 · Cited by 51
Neutrophils Mediate Maturation and Efflux of Lung Dendritic Cells in Response to Aspergillus fumigatus Germ Tubes
Park, S. J., Burdick, M. D., & Mehrad, B. (2012) · Infection and Immunity · doi:10.1128/iai.00097-12 · Cited by 51
Modulating host immune responses to fight invasive fungal infections
Scriven, J. E., Tenforde, M. W., Levitz, S. M., & Jarvis, J. N. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.10.018 · Cited by 54
Combination Therapy for Invasive Fungal Infections
Livengood, S. J., Drew, R. H., & Perfect, J. R. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00369-4 · Cited by 51
Exploration of Sulfur Assimilation of Aspergillus fumigatus Reveals Biosynthesis of Sulfur-Containing Amino Acids as a Virulence Determinant
Amich, J., Dümig, M., O'Keeffe, G., Binder, J., Doyle, S., Beilhack, A., & Krappmann, S. (2016) · Infection and Immunity · doi:10.1128/iai.01124-15 · Cited by 48
The Crystal Structure of Peroxiredoxin Asp f3 Provides Mechanistic Insight into Oxidative Stress Resistance and Virulence of Aspergillus fumigatus
Hillmann, F., Bagramyan, K. A., Straßburger, M., Heinekamp, T., Hong, T., Bzymek, K. P., Williams, J. C., Brakhage, A. A., & Kalkum, M. (2016) · Scientific Reports · doi:10.1038/srep33396 · Cited by 47
Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis
Longworth, S. A., Blumberg, E. A., Barton, T. D., & Vinnard, C. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.001 · Cited by 44
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies
Hachem, R. Y., Assaf, A. D., Numan, Y., Shah, P., Jiang, Y., Chaftari, A., & RAAD, I. I. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.021 · Cited by 44
Donor-derived filamentous fungal infections in solid organ transplant recipients
Gómez, C. A., & Singh, N. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283630e4d · Cited by 42
A new and clinically relevant murine model of solid-organ transplant aspergillosis
Herbst, S., Shah, A., Carby, M. R., Chusney, G. D., Naresh, K. N., Dorling, A., Bignell, E., Shaunak, S., & Armstrong-James, D. P. H. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010330 · Cited by 40
Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics
Townsend, R. W., Akhtar, S., Alcorn, H. W., Berg, J. K., Kowalski, D. L., MUJAIS, S. K., & Desai, A. V. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2213-7 · Cited by 39
Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients
Miceli, M. H., Churay, T. L., Braun, T., Kauffman, C. A., & Couriel, D. R. (2017) · Mycopathologia · doi:10.1007/s11046-017-0115-y · Cited by 38
Self-citation
Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis
Lewis, R. E., Georgiadou, S. P., Sampsonas, F., Chamilos, G., & Kontoyiannis, D. P. (2013) · Mycoses · doi:10.1111/myc.12101 · Cited by 38
Self-citation
Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study
Park, J. H., Ryu, S. H., Lee, J.-Y., Kim, H. J., Kwak, S. H., Jung, J., Lee, J., Sung, H., & Kim, S. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0543-1 · Cited by 37
Invasive Aspergillosis in the Intensive Care Unit
Townsend, L., & Martín‐Loeches, I. (2022) · Diagnostics · doi:10.3390/diagnostics12112712 · Cited by 42
Invasive pulmonary Aspergillosis in organ transplants – Focus on lung transplants
Geltner, C., & Lass‐Flörl, C. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.08.005 · Cited by 36
Treatment Principles for the Management of Mold InfectionsPreprint
Kontoyiannis, D. P., & Lewis, R. E. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019737 · Cited by 36
Self-citation
Invasive mold infections in lung and heart‐lung transplant recipients: Stanford University experience
Vazquez, R., Guillamet, C. V., Suarez, J., Mooney, J. J., Montoya, J. G., & Dhillon, G. S. (2015) · Transplant Infectious Disease · doi:10.1111/tid.12362 · Cited by 35
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis
Baddley, J. W., Andes, D. R., Marr, K. A., Kauffman, C. A., Kontoyiannis, D. P., Ito, J. I., Schuster, M. G., Brizendine, K. D., Patterson, T. F., Lyon, G. M., et al. (2013) · Medical Mycology · doi:10.3109/13693786.2012.690108 · Cited by 34
Self-citation
Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia
Qiao, B., Wu, J., Wan, Q., zhang, S., & Ye, Q. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2276-1 · Cited by 35
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms
Arendrup, M. C., Hare, R. K., & Cuenca‐Estrella, M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02336-15 · Cited by 34
MDA5 Is an Essential Sensor of a Pathogen-Associated Molecular Pattern Associated with Vitality That Is Necessary for Host Resistance against Aspergillus fumigatus
Wang, X., Caffrey-Carr, A. K., Liu, K.-W., Espinosa, V., Croteau, W., Dhingra, S., Rivera, A., Cramer, R. A., & Obar, J. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000802 · Cited by 33
Impact ofIn VivoTriazole and Echinocandin Combination Therapy for Invasive Pulmonary Aspergillosis: Enhanced Efficacy againstCyp51Mutant Isolates
Lepak, A. J., Marchillo, K., VanHecker, J., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00833-13 · Cited by 33
Self-citation
Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and Risk Factors
Şahin, S. Z., Akalın, H., Ersoy, A., Yıldız, A., Ocakoğlu, G., Çetinoğlu, E. D., Dizdar, O. S., Kazak, E., & Ener, B. (2015) · Mycopathologia · doi:10.1007/s11046-015-9875-4 · Cited by 33
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease
van der Elst, K. C. M., Brouwers, C. H. S., van den Heuvel, E. R., van Wanrooy, M. J. P., Uges, D. R. A., van der Werf, T. S., Kosterink, J. G. W., Span, L. F. R., & Alffenaar, J. C. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000235 · Cited by 33
Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis
Zelante, T., Wong, A. Y. W., Mencarelli, A., Foo, S., Zolezzi, F., Lee, B., Poidinger, M., Ricciardi-Castagnoli, P., & Fric, J. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.52 · Cited by 32
Immunomodulatory Potential of Fungal Extracellular Vesicles: Insights for Therapeutic Applications
Nenciarini, S., & Cavalieri, D. (2023) · Biomolecules · doi:10.3390/biom13101487 · Cited by 34
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections
Nosari, A., Caira, M., Pioltelli, M. L., Fanci, R., Bonini, A., Cattaneo, C. M., Castagnola, C., Capalbo, S. F., de Fabritiis, P., Mettivier, V., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12014 · Cited by 32
Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis
Shirkhani, K., Teo, I. A., Armstrong-James, D. P. H., & Shaunak, S. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.02.012 · Cited by 31
Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging
Poelmans, J., Hillen, A., Vanherp, L., Govaerts, K., Maertens, J. A., Dresselaers, T., Himmelreich, U., Lagrou, K., & Velde, G. V. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.45 · Cited by 31

Authors: Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G., Wingard, J. R., Patterson, T. F., Ito, J. I., Williams, O. D., Chiller, T., & Pappas, P. G.
Affiliations: University of Alabama (US)
University of Wisconsin–Madison (US)
Johns Hopkins University (US)
The University of Texas MD Anderson Cancer Center (US)
Duke University (US)
University of Michigan (US)
University of Arkansas at Little Rock (US)
National Institutes of Health (US)
University of Pennsylvania (US)
University of Florida (US)
The University of Texas at San Antonio Health Science Center (US)
City Of Hope National Medical Center (US)
Centers for Disease Control and Prevention (US)
Corresponding author: Baddley, John W.
ORCID: Baddley, John W.
Andes, David R.
Marr, Kieren A.
Kontoyiannis, Dimitrios P.
Alexander, Barbara D.
Oster, Robert A.
Walsh, Thomas J.
Schuster, Mindy G.
Wingard, John R.
Patterson, Thomas F.
Chiller, Tom
Pappas, Peter G.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2010-06-15
Volume: 50
Issue: 12
Pages: 1559-1567
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1086/652768
PMC: PMC2874071
OpenAlex: W2133167433
Cited by: 303
References: 32
Citations by year: 2026: 7 · 2025: 14 · 2024: 13 · 2023: 13 · 2022: 14 · 2021: 13 · 2020: 17 · 2019: 16 · 2018: 10 · 2017: 29 · 2016: 30 · 2015: 29 · 2014: 20 · 2013: 18 · 2012: 30
FWCI: 16.18
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
Funders: National Institutes of Health (and K24)
Centers for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases (K24AI072522, K23AI064613)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords: invasive aspergillosis, mortality, hematopoietic stem cell transplantation, solid organ transplantation, prognostic factors, neutropenia, renal failure, liver dysfunction, methylprednisolone, amphotericin B, antifungal therapy, malnutrition, central nervous system disorders, race
MeSH terms: Adult, Antifungal Agents, Aspergillosis, Female, Humans, Male, Middle Aged, Postoperative Complications, Risk Factors, Cohort Studies, Organ Transplantation, Hematopoietic Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks